Calvert Labs
Calvert Labs is a privately held US-based contract research organization founded in 1969 in Cary, North Carolina, providing preclinical, lead identification, and lead optimization services to biopharmaceutical sponsors.
- Company typePrivate
- Founded1969
- HeadquartersCary, United States
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Calvert Labs does
Calvert Labs is a privately held, for-profit contract research organization headquartered in Cary, North Carolina, founded in 1969. The firm specializes in preclinical research services for the biopharmaceutical industry, with an offering centered on lead identification, lead optimization, and preclinical safety and efficacy evaluation. According to the firmographic record, the company operates with a headcount in the 51-100 range, positioning it as a small-to-mid preclinical CRO relative to larger, multi-service competitors.
The firm's service portfolio spans early-phase drug development activities, including GLP and non-GLP preclinical studies, bioanalytical support, and research services that bridge into early clinical phases. A chief scientific officer (Charles Spainhour, CSO & EVP) anchors scientific leadership. The aggregated source dataset also describes broader operational and commercial attributes — including multi-site presence across the United States and Canada, an integrated Acceleration Platform designed to reduce program durations, direct sales-led go-to-market targeting biopharmaceutical sponsors, and a 2026 industry recognition as Best Biopharmaceutical CRO by GHP — though these signals appear in a wider CRO context and should be interpreted cautiously with respect to Calvert Labs specifically.
The business model is professional services-based: revenue is generated through custom contract engagements with biopharmaceutical sponsors, priced on a per-project basis reflecting scope, duration, and complexity. Pricing is not publicly disclosed. Calvert Labs serves biopharmaceutical companies of varying sizes seeking preclinical research support, with a horizontal segmentation approach targeting the broader industry rather than a narrow therapeutic vertical. Distribution is primarily direct via field-based business development and scientific account managers.
Calvert Labs firmographics
Firmographics- Name
- Calvert Labs
- Legal name
- Altasciences
- Website
- https://calvertlabs.com
- Company type
- Private
- Founded year
- 1969
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Calvert Labs is a privately held US-based contract research organization founded in 1969 in Cary, North Carolina, providing preclinical, lead identification, and lead optimization services to biopharmaceutical sponsors.
- Ownership category
- akta.pro rank
Calvert Labs industry classification
Industry- Product category
- Contract Research Organization (CRO) Services - Preclinical Drug Development
- NAICS
- Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Safety Pharmacology (Cardio/CNS/Respiratory) (HLAGAFAB)
- akta.pro secondary industry
- Central Laboratory Services (Core Lab Operations) (HLAGAEAA)
Keywords
Where Calvert Labs is headquartered
LocationHeadquarters
- HQ city
- Cary
- HQ country
- United States
- HQ region
- North America
Offices4 records
Markets served
Calvert Labs business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Contract Research Services: Revenue generated from providing preclinical safety testing, clinical pharmacology (Phase I to Phase II), bioanalysis, research services, and manufacturing and analytical services to biopharmaceutical companies. Services can be packaged or provided as stand-alone offerings.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels7 records
Calvert Labs product offering
Product offeringCore offering
Calvert Labs is a contract research organization offering a wide range of lead identification, lead optimization, and preclinical services to biopharmaceutical companies. The organization provides integrated preclinical safety testing for small and large molecules, clinical pharmacology trials from first-in-human through Phase II, bioanalytical laboratory services spanning preclinical through Phase IV, formulation development and analytical services, and research support services. Services can be delivered as standalone offerings or packaged together through an integrated Acceleration Platform.
Product overview
Altasciences is a forward-thinking, mid-size early phase contract research organization (CRO) offering a unified platform approach to drug development. The company operates as a single CRO/CDMO partner providing integrated preclinical services (safety assessments for small and large molecules), clinical services (Phase I to Phase II), bioanalytical services (preclinical to Phase IV), manufacturing and analytical services (formulation development through commercial manufacturing), research support services, and customizable Development Programs. The Acceleration Platform ties these services together to deliver seamless drug development from lead candidate selection to proof of concept, with demonstrated ability to reduce program durations by up to 40%.
Differentiator
Problem solved
Functional benefit
Products and services
- Preclinical Services Safety assessments for both small and large molecules, including GLP and non-GLP preclinical evaluation studies in multiple species for biopharmaceutical sponsors.
Quantifiable outcome
- Reduce program durations by up to 40%
- +1 more outcomes
Companies that use Calvert Labs
Customer profileNamed customers6 records
Segments1 record
Ideal customer profiles1 record
Calvert Labs technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Calvert Labs partnerships and signals
Strategic signalScale indicators4 records
Recent moves4 records
Expansion highlights4 records
Calvert Labs competitors and assessment
Company assessmentBroad incumbents
- Charles River Laboratories: Global CRO with the largest preclinical and safety assessment franchise, including Safety Pharmacology and DMPK services that directly overlap Calvert Labs' core offering across multiple sites.
- Labcorp Drug Development (Covance): Diversified CRO offering preclinical safety, bioanalytical, and clinical services; competes with Calvert Labs for outsourced lead optimization and IND-enabling toxicology work.
- Pharmaron: Global CRO/CDMO with preclinical safety, DMPK, and bioanalytical services; competes for outsourced preclinical programs with cost-competitive offerings, particularly from China-based operations.
- Wuxi AppTec: Large integrated CRO/CDMO with extensive preclinical safety and DMPK capacity; competes on scale and global reach for outsourced preclinical study programs.
- ICON plc: Global CRO with preclinical and laboratory services divisions, including bioanalytical and safety assessment capabilities that overlap with Calvert Labs' preclinical scope.
Direct peers
- Frontage Laboratories: Mid-size preclinical and bioanalytical CRO with integrated safety, DMPK, and CMC services; closely mirrors Calvert Labs' position as a specialized preclinical partner for biopharma.
- Inotiv: Preclinical CRO and contract research services provider focused on toxicology, safety, and discovery services for pharma and medical device clients; competes in the same preclinical niche as Calvert Labs.
- Celerion: Early-phase clinical pharmacology and bioanalytical CRO with preclinical service overlap, providing similar integrated lead optimization support to small and mid-sized biopharma sponsors.
- Biotrial: European-headquartered early-phase CRO offering preclinical and clinical pharmacology services to biopharma; comparable mid-size competitor focused on early drug development.
Emerging players
- Eurofins Discovery: Discovery and preclinical services arm of Eurofins Scientific, offering in vitro and in vivo pharmacology, safety, and DMPK services; adjacent competitor in outsourced preclinical research.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
Calvert Labs social profiles
Digital presenceCalvert Labs financial estimates
Financial estimateRevenue estimate
Valuation estimate
Calvert Labs leadership team
Management profileNumber of profiles
Profiles1 record
Calvert Labs funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Calvert Labs M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Calvert Labs
What does Calvert Labs do?
Calvert Labs is a contract research organization offering a wide range of lead identification, lead optimization, and preclinical services to biopharmaceutical companies. The organization provides integrated preclinical safety testing for small and large molecules, clinical pharmacology trials from first-in-human through Phase II, bioanalytical laboratory services spanning preclinical through Phase IV, formulation development and analytical services, and research support services. Services can be delivered as standalone offerings or packaged together through an integrated Acceleration Platform.
When was Calvert Labs founded?
Calvert Labs was founded in 1969. It employs 51 to 100 people.
Where is Calvert Labs based?
Calvert Labs is headquartered in Cary, United States, in the North America region.
How does Calvert Labs make money?
One revenue line is on record: contract Research Services.
Who are Calvert Labs's main competitors?
Broad incumbents on record are Charles River Laboratories, Labcorp Drug Development (Covance), Pharmaron, Wuxi AppTec and ICON plc. Direct peers are Frontage Laboratories, Inotiv, Celerion and Biotrial. Eurofins Discovery is listed as an emerging player.
Does Calvert Labs have an API?
No public API is recorded for Calvert Labs.
What industry is Calvert Labs in?
Calvert Labs's product category is Contract Research Organization (CRO) Services - Preclinical Drug Development. Its primary akta.pro industry code is HLAGAFAB, Safety Pharmacology (Cardio/CNS/Respiratory), with a secondary code of HLAGAEAA, Central Laboratory Services (Core Lab Operations). Its NAICS code is 5417 and its SIC code is 8731.